Package Leaflet: Information for the Patient
Fuzeon 90mg/ml powder and solvent for solution for injection
Enfuvirtide
Read allof this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
What is Fuzeon
Fuzeon contains the active substance “enfuvirtide” and belongs to a group of medicines called “antiretrovirals”.
What Fuzeon is used for
Fuzeon is used for the treatment of the Human Immunodeficiency Virus (HIV) in combination with other antiretroviral medicines in patients infected with HIV.
How Fuzeon works
HIV attacks cells in your blood known as CD4 or T lymphocytes. The virus needs to come into contact with them and gets inside these cells to multiply. Fuzeon helps prevent this.
Do not use Fuzeon if
If you are not sure, talk to your doctor, pharmacist, or nurse before using Fuzeon.
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before starting Fuzeon if:
Signs of previous infections
In some patients with advanced HIV infection (AIDS) and a history of opportunistic infections, signs and symptoms of inflammation of previous infections may appear soon after starting anti-HIV treatment. These symptoms are thought to be due to an improvement in the body's immune response. This improvement enables the body to fight infections that were already present but not showing any symptoms. If you notice any symptoms of infection, please inform your doctor immediately.
Signs of autoimmune disorders
In addition to opportunistic infections, autoimmune disorders (a condition that occurs when the immune system attacks healthy body tissue) may also appear after you have started taking medicines for the treatment of your HIV infection. Autoimmune disorders may appear many months after starting treatment. If you notice any symptoms of infection or other symptoms such as muscle weakness, weakness starting in the hands and feet and moving up towards the trunk of the body, palpitations, tremors, or hyperactivity, inform your doctor immediately to receive the necessary treatment.
Patients with liver disease
Patients with chronic hepatitis B or C who are on anti-HIV therapy are at a greater risk of experiencing serious liver problems. Talk to your doctor if you have a history of liver disease.
Bone disease (osteonecrosis)
Some patients who receive combination anti-HIV therapy may develop a bone disease called osteonecrosis. Bone tissue dies because the blood supply to the bone is lost (bone tissue death due to loss of blood supply to the bone).
Using Fuzeon with other medicines
Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use any other medicines. This includes medicines without a prescription and herbal medicines. Fuzeon has not shown interactions with other medicines that are part of your anti-HIV treatment or with rifampicin (an antibiotic).
Using Fuzeon with food and drinks
You can use Fuzeon with or without food. However, you should follow the instructions indicated in the leaflets of the other medicines you are taking.
Pregnancy and breastfeeding
Driving and using machines
The effects of Fuzeon on the ability to drive or use machines have not been studied. You should not drive or use machines if you feel dizzy while using Fuzeon.
Fuzeon contains sodium
Fuzeon contains less than 1 mmol of sodium (23 mg) per dose; this is essentially “sodium-free”.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
How to prepare and inject Fuzeon
Fuzeon must be administered as an injection under the skin – called “subcutaneous injection”. In section 7, it is indicated how to prepare Fuzeon and how to self-administer an injection.
How much to use
Consult the end of this leaflet for additional information on how to use Fuzeon (see section 7). There you will find instructions on how to prepare Fuzeon and how to administer the injection yourself.
If you use more Fuzeon than you should
If you use more Fuzeon than you should, talk to your doctor or go to the hospital immediately. Take the medicine package with you.
If you forget to use Fuzeon
If you stop using Fuzeon
If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop using Fuzeon and contact your doctor immediately if you notice any of the following serious side effects because you may need urgent medical treatment:
This side effect is rare (affects less than 1 in 1,000 people). These signs do not necessarily mean that you are allergic to this medicine.
Talk to your doctor if you have side effects at the injection site
The most common side effects (affect more than 1 in 10 people) are problems at the injection site. It is very likely that you will have one or more of the following reactions, which are usually mild to moderate:
These reactions may appear in the first week of treatment and usually only last up to 7 days. They usually do not get worse after this time. If you have any of these reactions, do not stop using Fuzeon but talk to your doctor.
These reactions may worsen when the injection is repeated at the same site on the body. They may also worsen when the injection is given more deeply than intended (for example, into the muscle). Rarely, you may have an infection at the injection site. To minimize the risk of infection, it is important that you follow the instructions in section 7.
Fuzeon may cause a buildup of a type of protein called amyloid under the skin at the injection site. You may notice lumps under the skin. Please contact your doctor if this happens.
Other possible side effects
Very common(affect more than 1 in 10 people)
Common(affect up to 1 in 10 people)
Reporting side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label of the Fuzeon vials or on the label of the vials of Water for Injections after “EXP”. The expiry date is the last day of the month shown.
Store the vial in the outer packaging to protect it from light.
Once the solution is prepared, the injection should be administered immediately. If it is not administered immediately, store it in the refrigerator (between 2°C and 8°C) and use it before 24 hours.
Do not use this medicine if you notice any particles in the powder or in the solution after adding the water for injections. Also, do not use the water for injections if you notice particles in the vial or if the water is cloudy.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Fuzeon
Powder
Sodium carbonate anhydrous
Mannitol
Sodium hydroxide
Hydrochloric acid
Solvent
Water for injectable preparations
See section 2 "Fuzeon contains sodium".
Appearance of the Product and Container Contents
Fuzeon, powder and solvent for injectable solution, consists of a package containing:
60 vials of Fuzeon
60 vials of Water for injectable preparations used to reconstitute the Fuzeon powder
60 3-ml syringes
60 1-ml syringes
180 alcohol swabs
This package includes everything needed to prepare and inject Fuzeon for 30 days of treatment.
Marketing Authorization Holder
Roche Registration GmbH
Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany
The manufacturer responsible for batch release is
Roche Pharma AG
Emil-Barell-Str. 1,
D-79639 Grenzach-Wyhlen
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Czech Republic Roche s.r.o. Tel: +420 - 2 20382111 | Malta (See Ireland) |
Denmark Roche Pharmaceuticals A/S Tlf: +45 - 36 39 99 99 | Netherlands Roche Nederland B.V. Tel: +31 (0) 348 438050 |
Germany Roche Pharma AG Tel.: +49 (0) 7624 140 | Norway Roche Norge AS Tel.: +47 - 22 78 90 00 |
Estonia Roche Eesti OÜ Tel.: + 372 - 6 177 380 | Austria Roche Austria GmbH Tel.: +43 (0) 1 27739 |
Greece Roche (Hellas) A.E. Tel.: +30 210 61 66 100 | Poland Roche Polska Sp.z o.o. Tel.: +48 - 22 345 18 88 |
Spain Roche Farma S.A. Tel: +34 - 91 324 81 00 | Portugal Roche Farmacêutica Química, Lda Tel.: +351 - 21 425 70 00 |
France Roche Tel: +33 (0) 1 47 61 40 00 | Romania Roche România S.R.L. Tel.: +40 21 206 47 01 |
Croatia Roche d.o.o. Tel.: +385 1 4722 333 | Slovenia Roche farmacevtska družba d.o.o. Tel.: +386 - 1 360 26 00 |
Ireland Roche Products (Ireland) Ltd. Tel.: +353 (0) 1 469 0700 | Slovak Republic Roche Slovensko, s.r.o. Tel.: +421 - 2 52638201 |
Iceland Roche Pharmaceuticals A/S c/o Icepharma hf Tel: +354 540 8000 | Finland Roche Oy Tel: +358 (0) 10 554 500 |
Italy Roche S.p.A. Tel.: +39 - 039 2471 | Sweden Roche AB Tel.: +46 (0) 8 726 1200 |
Cyprus Γ.Α.Σταμ?της & Σια Λτδ. Tel.: +357 - 22 76 62 76 | United Kingdom (Northern Ireland) Roche Products (Ireland) Ltd. Tel: +44 (0) 1707 366000 |
Latvia Roche Latvija SIA Tel.: +371 - 6 7039831 | |
Date of Last Revision of this Leaflet:
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor, pharmacist, or nurse again.
What to Do if You Are Left-Handed
The drawings in this leaflet show right-handed people. If you are left-handed, act naturally. You may find it more convenient:
? to hold the syringe with your left hand and
? to take the vial between the thumb and index finger of your right hand.
When to Ask for Help from Support Staff
At first, it may be difficult to inject in some places, such as the arm. Ask for help if you need it, to your partner, a friend, or a family member. You may want to ask someone to accompany you to a training session on the injection technique with your doctor or nurse.
The Syringes
The syringes supplied with this medication have a colored needle protector. This is attached to the needle and covers the needle after use to reduce the risk of accidentally pricking someone else with the needle. Although these syringes have this safety feature, it is important that you dispose of them properly after use. Follow the instructions given by your doctor, pharmacist, or nurse.
Safety Tips
? Wash your hands thoroughly. This will reduce the risk of bacterial infections.
? Once you have washed your hands, do not touch anything except the medication and the material provided for the injection.
? When handling the syringe, do not touch the needle.
? Do not touch the vial stoppers once they have been cleaned with the alcohol swabs.
? Never use opened materials. Before using, check that all elements of the package are closed.
? Never use or share used needles.
? Never use a bent or damaged needle.
? Never mix the medication with tap water.
? Never inject the medication with other injectable medications.
? Only inject Fuzeon under the skin ("subcutaneously").
? Do not inject Fuzeon into a vein ("intravenously") or into a muscle ("intramuscularly").
? Dispose of all used material in the container with a lid for disposable materials. Do this even if the vials contain unused amounts of medication or water for injectable preparations, as these are for single use. Consult your doctor, pharmacist, or nurse if you have any doubts about the safe disposal of this material.
The following is a basic, step-by-step guide to injecting the medication.
Step A: To Begin
? A vial of Fuzeon (glass container with white powder inside)
? A vial of water for injectable preparations (glass container with clear, colorless liquid inside)
? A 3-ml syringe (large syringe) with a 25-mm needle
? A 1-ml syringe (small syringe) with a 13-mm needle
? Three alcohol swabs
? A container with a lid for safe disposal of disposable materials
? Place the packages and vial caps in the container with a lid for disposable materials.
? Place the syringes and vials on a clean surface.
? After washing your hands, do not touch anything except the injection material and the area where you will administer the injection.
? Clean each vial stopper with a new, clean alcohol swab. Let the stopper air dry.
? Make sure you do not touch the rubber stoppers once they are cleaned. If you do, make sure to clean them again.
Step B: Preparation of the Fuzeon Mixture
Withdraw Water for Injectable Preparations
? hold the plastic cap below the needle protector
? gently twist and push the needle and cap into the syringe. Do not apply too much force, as the needle may loosen.
? hold the syringe and pull off the cap.
? If too much air has entered the syringe, gently push the plunger to return the air bubbles to the vial.
? Then withdraw the water again,
? Make sure you have 1.1 ml of water for injectable preparations in the syringe.
? This step can be repeated until you have the correct amount of water for injectable preparations in the syringe.
Inject Water for Injectable Preparations into the Fuzeon Vial
? Allow the water to flow down the inner walls of the vial.
? Avoid injecting the water abruptly onto the powder, as foam may form.
? If foam forms, the powder may take longer to dissolve completely.
Mixing Water for Injectable Preparations with Fuzeon Powder
? The powder may take up to 45 minutes to dissolve.
? The patient can gently roll the vial between their hands after adding the water for injectable preparations until the powder is completely dissolved.
? This can reduce the time it takes to dissolve.
? Let any bubbles that have formed settle.
? If there are still bubbles, gently tap the sides of the vial to make them settle.
? If you notice any particles in the liquid, do not use it.
? Discard the vial in the container with a lid for disposable materials or return it to the pharmacy. Start again with a new vial of Fuzeon powder.
? Wait for the liquid to reach room temperature before using it.
Step C: Preparation for Administration of the Injection
Withdraw Fuzeon with the 1-ml Syringe
? hold the plastic cap below the needle protector
? gently twist and push the needle and cap into the syringe.
? hold the syringe and pull off the cap.
? Be careful not to pull the plunger too quickly - you might exceed the 1-ml mark or pull out the syringe.
Make sure the needle tip remains below the surface of the solution so that no air bubbles enter the syringe.
? Be careful not to pull the plunger too quickly - you might exceed the 1-ml mark or pull out the syringe.
? If too much air enters the syringe, gently push the plunger to return the air to the vial.
? Then withdraw the liquid again.
? Make sure you have 1.0 ml of liquid in the syringe (or the amount prescribed by your doctor, if different).
? This step can be repeated until the correct amount of solution is inside the syringe.
Step D: Injection of Fuzeon
Advice:Your doctor or nurse will suggest different injection techniques that may be more suitable for you.
Where to Inject
? Fuzeon is administered in a 1-ml injection under the skin - known as "subcutaneous injection".
? You can inject it into your arms, the front of your thigh, or the abdominal area (abdomen).
? Choose a different area from the last injection you received.
? Do not inject the medication into a site where there is still a reaction from the previous dose. Check the areas where there may be a reaction by pressing the skin to see if there are hard lumps.
? Do not inject the medication into areas that may be irritated by a belt or by rubbing against clothing.
? Do not inject the medication into moles, scars, bruises, or the navel.
Clean the Injection Site
Clean the injection site with an alcohol swab in a circular motion outward. Let the area dry completely.
Insert the Needle and Administer the Injection
? release the skin
? with your free hand, hold the main part of the syringe - this will help keep it straight and prevent it from moving.
Once the entire dose has been injected, remove the needle from the skin.
After removing the needle
Then, over a flat surface, gently press down on the colored needle shield until the needle is covered by the shield.
You will hear a click.
Do not use your free hand to press the shield over the needle.
Step E: How to dispose of used materials
Discard all used materials directly into the container with a lid for disposable materials. Do this even if the vials contain remnants of the medication or water for injectable preparations, as they are for single use.
Always keep the container lid closed and place it out of the reach of children.
Ask your doctor, pharmacist, or nurse how to properly dispose of the container.
If you have any doubts or concerns about the safe disposal of materials, consult with your doctor, pharmacist, or nurse.